| Literature DB >> 31366345 |
Akihiko Hiyama1, Hiroyuki Katoh2, Daisuke Sakai2, Masahiro Tanaka2, Masato Sato2, Masahiko Watanabe2.
Abstract
BACKGROUND: The relationship between spinal alignment and skeletal muscle mass (SMM) has attracted attention in recent years. Sagittal alignment is known to deteriorate with age, but it is not known whether this is related to paraspinal muscles. Therefore, the purpose of this study is to elucidate the role of the multifidus (MF) and psoas major (PS) muscles in maintaining global spinal alignment in patients with lumbar spinal stenosis (LSS) and/or degenerative spondylolisthesis (DS), and to analyze whether each muscles' cross-sectional area (CSA) correlates with whole-body SMM using bioimpedance analysis (BIA).Entities:
Keywords: Bioimpedance analysis (BIA); Cross-sectional area (CSA); Pelvic tilt (PT); Skeletal muscle mass (SMM); Spinal alignment
Mesh:
Year: 2019 PMID: 31366345 PMCID: PMC6668152 DOI: 10.1186/s12891-019-2733-7
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1Standing-erect whole-spine posteroanterior and lateral full-spine radiographs. Measurement of sagittal parameters. Thoracic kyphosis (TK) was the Cobb’s angle between upper end plate of T5 and lower end plate of T12. Lumbar lordosis (LL) was the Cobb’s angle between upper end plate of L1 and S1. Pelvic incidence (PI) was the angle between the perpendicular to the sacral plate at its midpoint and the line connecting this point to the middle axis of both femoral heads. Pelvic tilt (PT) was the angle between the line connecting the midpoint of the sacral plate to the axis of the femoral heads and the line perpendicular to the floor. Sacral slope (SS) is defined as the angle subtended by the horizontal line and upper sacral end plate. Sagittal vertical axis (C7-SVA) was the distance between the C7 plumb line and the postero- superior corner of S1
Fig. 2Axial slice by spinal levels. Measurement of cross-sectional area (CSA) of psoas (PS) and multifidus (MF)
Summary of characteristics in 140 study patients. BMI; body mass index, NRS; numeric rating scale, LBP; low back pain, CL;cervical lordosis (C2–C7), TK; thoracic kyphosis (T5–12), LL; lumbar lordosis (T12–S1), SS; sacral slope, PI; pelvic incidence, PT; pelvic tilt, SS; sacral slope, SVA; sagittal vertical axis. All values are expressed as mean value ± standard deviation
| Overall | Male | Female | ||
|---|---|---|---|---|
| Number of Cases | 140 | 67 | 73 | |
| Age (yrs) | 70.6 ± 9.0 | 70.9 ± 9.4 | 70.4 ± 8.6 | 0.724 |
| Height (cm) | 158.2 ± 9.6 | 165.0 ± 7.9 | 152.0 ± 6.3 | < 0.001 |
| Body weight (kg) | 61.5 ± 12.8 | 67.5 ± 12.8 | 56.1 ± 10.3 | < 0.001 |
| BMI (kg/m2) | 24.4 ± 4.0 | 24.7 ± 3.3 | 24.2 ± 4.5 | 0.153 |
| NRS of LBP | 5.5 ± 2.8 | 5.6 ± 2.8 | 5.5 ± 2.7 | 0.984 |
| Radiological parameters | ||||
| CL | 8.9 ± 14.3 | 9.4 ± 15.1 | 8.4 ± 13.8 | 0.358 |
| TK | 25.2 ± 9.8 | 25.7 ± 9.1 | 24.8 ± 10.4 | 0.809 |
| LL | 32.2 ± 15.8 | 31.7 ± 14.4 | 32.7 ± 17.0 | 0.404 |
| PI | 50.1 ± 9.6 | 47.8 ± 8.6 | 52.2 ± 10.1 | < 0.01 |
| PT | 23.6 ± 9.0 | 21.5 ± 7.8 | 25.5 ± 9.6 | < 0.05 |
| SS | 26.0 ± 9.2 | 25.9 ± 10.0 | 26.2 ± 8.5 | 0.470 |
| C7-SVA | 65.4 ± 55.1 | 67.6 ± 51.7 | 63.4 ± 58.4 | 0.490 |
Results of BIA body compositions analysis, muscle-fat analysis, obesity estimation, and body water analysis. SMM; skeletal muscle mass, BIA; bioimpedance analysis, ICW; intracellular water, ECW; extracellular water, TBW; total body water. All values are expressed as mean value ± standard deviation
| BIA | Overall | Male | Female | |
|---|---|---|---|---|
| ICW (ℓ) | 19.1 ± 4.4 | 22.1 ± 3.8 | 16.4 ± 3.0 | < 0.001 |
| ECW (ℓ) | 12.4 ± 2.7 | 14.2 ± 2.2 | 10.8 ± 1.9 | < 0.001 |
| ECW/TBW (Leg) | 0.398 ± 0.015 | 0.396 ± 0.015 | 0.399 ± 0.014 | 0.157 |
| ECW/TBW (Whole body) | 0.395 ± 0.012 | 0.393 ± 0.012 | 0.397 ± 0.011 | < 0.05 |
| Protein (kg) | 8.3 ± 1.9 | 9.5 ± 1.7 | 7.1 ± 1.3 | < 0.001 |
| Mineral (kg) | 2.9 ± 0.6 | 3.3 ± 0.6 | 2.6 ± 0.4 | < 0.001 |
| Soft lean mass (kg) | 40.3 ± 9.1 | 46.4 ± 7.8 | 34.6 ± 6.2 | < 0.001 |
| Skeletal muscle mass (SMM) (kg) | 22.9 ± 5.8 | 26.8 ± 5.0 | 19.4 ± 3.9 | < 0.001 |
| Body fat mass (kg) | 18.7 ± 7.8 | 18.4 ± 8.0 | 19.0 ± 7.7 | 0.422 |
| Percent body fat (%) | 30.1 ± 9.3 | 26.6 ± 7.9 | 33.3 ± 9.3 | < 0.001 |
Comparison of PS and MF CSAs by spinal levels. PS, Psoas; MF, Multifidus; CSA, Cross-sectional area. All values are expressed a mean ± standard deviation. *** p< 0.001 indicates significant differences between groups
| PS (mm2) |
| MF (mm2) |
| ||||||
|---|---|---|---|---|---|---|---|---|---|
| Overall | Male | Female | Overall | Male | Female | ||||
| L3-L4 | 751.6 ± 300.5 | 964.3 ± 251.7 | 556.4 ± 188.4 | *** | 351.3 ± 113.1 | 402.6 ± 97.0 | 304.2 ± 106.7 | *** | |
| Left | L4-L5 | 1001.3 ± 329.8 | 1237.0 ± 289.0 | 784.8 ± 185.1 | *** | 459.3 ± 148.6 | 542.3 ± 135.5 | 382.2 ± 115.5 | *** |
| L5-S1 | 882.1 ± 320.4 | 1080.8 ± 302.6 | 699.8 ± 209.2 | *** | 482.8 ± 153.7 | 551.5 ± 139.5 | 419.7 ± 139.0 | *** | |
| L3-L4 | 790.0 ± 337.9 | 1038.5 ± 291.5 | 561.8 ± 179.8 | *** | 366.4 ± 113.4 | 422.8 ± 98.6 | 314.7 ± 101.2 | *** | |
| Right | L4-L5 | 1010.3 ± 364.7 | 1282.9 ± 294.5 | 760.0 ± 211.2 | *** | 473.7 ± 144.3 | 549.9 ± 129.8 | 403.8 ± 120.1 | *** |
| L5-S1 | 905.0 ± 337.3 | 1112.5 ± 338.2 | 720.3 ± 203.3 | *** | 485.4 ± 149.0 | 558.0 ± 128.6 | 418.8 ± 135.3 | *** | |
| L3-L4 | 770.8 ± 304.6 | 1001.4 ± 243.7 | 559.1 ± 172.6 | *** | 358.9 ± 106.6 | 412.7 ± 90.3 | 309.5 ± 96.5 | *** | |
| Ave | L4-L5 | 1005.8 ± 333.9 | 1260.0 ± 266.5 | 772.4 ± 186.5 | *** | 464.9 ± 140.5 | 546.1 ± 123.7 | 390.4 ± 111.0 | *** |
| L5-S1 | 887.1 ± 319.5 | 1080.0 ± 319.2 | 710.0 ± 193.1 | *** | 484.1 ± 144.6 | 554.7 ± 126.4 | 419.2 ± 129.6 | *** | |
Correlation coefficient analysis of SMM and CSAs of PS and MF. PS; Psoas, MF; Multifidus, CSA; Cross-Sectional Area. ***p< 0.001 indicates significant differences between groups
| SMM | PS | PS | PS | MF | MF | MF | |
|---|---|---|---|---|---|---|---|
| SMM | 1.000 | 0.723*** | 0.739*** | 0.654*** | 0.546*** | 0.582*** | 0.563*** |
| PS AveCSA (L3-L4) | 0.723*** | 1.000 | 0.877*** | 0.646*** | 0.500*** | 0.585*** | 0.496*** |
| PS AveCSA (L4-L5) | 0.739*** | 0.877*** | 1.000 | 0.797*** | 0.509*** | 0.566*** | 0.506*** |
| PS AveCSA (L5-S1) | 0.654*** | 0.646*** | 0.797*** | 1.000 | 0.343*** | 0.393*** | 0.420*** |
| MF AveCSA (L3-L4) | 0.546*** | 0.500*** | 0.509*** | 0.343*** | 1.000 | 0.690*** | 0.538*** |
| MF AveCSA (L4-L5) | 0.582*** | 0.585*** | 0.566*** | 0.393*** | 0.690*** | 1.000 | 0.682*** |
| MF AveCSA (L5-S1) | 0.563*** | 0.496*** | 0.506*** | 0.420*** | 0.538*** | 0.682*** | 1.000 |
Fig. 3Correlation between SMM and PS AveCSA or MF AveCSA at the each level in 140 patients. SMM; skeletal muscle mass.
Correlation coefficient analysis of spinal muscles, age and spinal alignment parameters. SMM; skeletal muscle mass, TK; thoracic kyphosis (T5–12), LL; lumbar lordosis (T12–S1), SS; sacral slope, PI; pelvic incidence, PT; pelvic tilt, SS; sacral slope, SVA; sagittal vertical axis, PS; Psoas. *p < 0.05, **< 0.01, ***< 0.001 indicates significant differences between groups
| SMM | Age | PS | TK | LL | PI | PT | SS | C7-SVA | |
|---|---|---|---|---|---|---|---|---|---|
| SMM | 1.000 | −0.307*** | – | −0.042 | −0.067 | −0.208* | −0.184* | −0.043 | 0.054 |
| Age | −0.307*** | 1.000 | −0.156* | 0.063 | 0.006 | 0.056 | 0.055 | 0.051 | 0.171* |
| PS AveCSA (L4-L5) | 0.739*** | − 0.156* | 1.000 | 0.014 | −0.005 | − 0.165* | − 0.183* | −0.004 | 0.035 |
| TK | −0.042 | 0.063 | 0.014 | 1.000 | 0.490*** | 0.196* | −0.034 | 0.232* | −0.021 |
| LL | −0.067 | 0.006 | −0.005 | 0.490*** | 1.000 | 0.447*** | −0.331*** | 0.780*** | −0.516*** |
| PI | −0.208* | 0.056 | −0.165* | 0.196* | 0.447*** | 1.000 | 0.447*** | 0.459*** | −0.041 |
| PT | −0.184* | 0.055 | −0.183* | −0.034 | − 0.331*** | 0.447*** | 1.000 | −0.498*** | 0.189* |
| SS | −0.043 | 0.051 | −0.004 | 0.232* | 0.780*** | 0.459*** | −0.498*** | 1.000 | −0.231* |
| C7-SVA | 0.054 | 0.171* | 0.035 | −0.021 | −0.516*** | − 0.041 | 0.189* | − 0.231* | 1.000 |
Correlation coefficient analysis of NRS of LBP and CSAs of PS and MF. PS; Psoas, MF; Multifidus, CSA; Cross-Sectional Area. NRS; numeric rating scale, LBP; low back pain
| PS | PS | PS | MF | MF | MF | |
|---|---|---|---|---|---|---|
| NRS | −0.026 | 0.004 | 0.080 | −0.103 | −0.198 | − 0.103 |